Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Date Time Source Announcement
15 Jan 2019 5:15 pm
RNS
Director/PDMR Shareholding
  4:09 pm
RNS
Director/PDMR Shareholding
  3:01 pm
RNS
Director/PDMR Shareholding
  2:59 pm
RNS
Director/PDMR Shareholding
  2:56 pm
RNS
Director/PDMR Shareholding
  2:47 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
GlaxoSmithKline Extends Tender Offer for TESARO
11 Jan 2019 4:32 pm
RNS
Director/PDMR Shareholding
  4:25 pm
RNS
Director/PDMR Shareholding
02 Jan 2019 1:45 pm
RNS
Total Voting Rights
20 Dec 2018 5:15 pm
RNS
Director/PDMR Shareholding
19 Dec 2018 7:00 am
RNS
GSK and Pfizer create new Consumer Healthcare JV
14 Dec 2018 1:20 pm
RNS
GSK Commences Tender Offer for TESARO Inc.
12 Dec 2018 4:35 pm
RNS
Director/PDMR Shareholding
04 Dec 2018 10:07 am
RNS
Director/PDMR Shareholding
03 Dec 2018 2:00 pm
RNS
Total Voting Rights
  12:02 pm
RNS
GSK reaches agreement to acquire TESARO
  8:35 am
RNS
GSK to divest Horlicks to Unilever
30 Nov 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
29 Nov 2018 3:40 pm
RNS
Director/PDMR Shareholding
  11:45 am
RNS
GSK - Update on Review of Horlicks
27 Nov 2018 3:25 pm
RNS
Block listing Interim Review
22 Nov 2018 1:02 pm
RNS
GSK publishes 2019 Dividend Dates
12 Nov 2018 2:45 pm
RNS
Director/PDMR Shareholding
  9:00 am
RNS
Blocklisting Application
08 Nov 2018 12:43 pm
RNS
Director Declaration
02 Nov 2018 4:15 pm
RNS
Director/PDMR Shareholding
01 Nov 2018 1:40 pm
RNS
Total Voting Rights
31 Oct 2018 2:15 pm
RNS
ViiV positive phIII results with fostemsavir
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
3rd Quarter Results
30 Oct 2018 2:30 pm
RNS
ViiV: positive data for long-acting injectable
29 Oct 2018 10:00 am
RNS
ViiV - three-year data for long-acting injectable
18 Oct 2018 4:00 pm
RNS
ViiV submits HIV 2DR regulatory application to FDA
  9:34 am
RNS
Director/PDMR Shareholding
17 Oct 2018 5:56 pm
RNS
Director/PDMR Shareholding
  5:50 pm
RNS
Director/PDMR Shareholding
  11:30 am
RNS
Director/PDMR Shareholding
16 Oct 2018 4:53 pm
RNS
Director/PDMR Shareholding
  9:30 am
RNS
Director/PDMR Shareholding
  9:30 am
RNS
Director/PDMR Shareholding
10 Oct 2018 3:30 pm
RNS
Director/PDMR Shareholding
01 Oct 2018 1:58 pm
RNS
Total Voting Rights
27 Sep 2018 4:35 pm
RNS
Director/PDMR Shareholding
21 Sep 2018 12:30 pm
RNS
CHMP recommends expansion of Trelegy COPD label
14 Sep 2018 9:00 am
RNS
ViiV submits HIV 2DR regulatory application to EMA
12 Sep 2018 5:43 pm
RNS
Director/PDMR Shareholding
10 Sep 2018 8:00 am
RNS
New analysis on efficacy of anti-IL5 biologics SEA
  7:00 am
RNS
GSK receives CRL from FDA for mepolizumab in COPD
07 Sep 2018 2:24 pm
RNS
Director/PDMR Shareholding
  2:18 pm
RNS
Director/PDMR Shareholding
03 Sep 2018 5:00 pm
RNS
Total Voting Rights
30 Aug 2018 5:12 pm
RNS
GSK publishes Q4 2018 Dividend Dates
  8:12 am
RNS
EU approve Nucala in severe asthma in children
24 Aug 2018 10:16 am
RNS
Director/PDMR Shareholding
15 Aug 2018 7:00 am
RNS
Positive headline results for ViiV HC ATLAS study
10 Aug 2018 3:00 pm
RNS
Director/PDMR Shareholding
08 Aug 2018 12:35 pm
RNS
Director/PDMR Shareholding
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t